Cytosorbents Corp

NASDAQ:CTSO 4:00:00 PM EDT

1.06

+0.06 (+6.00%)

4:31:32 PM EDT: $1.02 -0.04 (-3.77%)

Market Cap (Intraday)	57.70M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$9.94 Million
Adjusted EPS	-$0.07

See more estimates

10-Day MA	$1.03
50-Day MA	$1.04
200-Day MA	$1.01

See more pivots

Cytosorbents Corp Stock, NASDAQ:CTSO

305 College Road East, Suite K, Princeton, New Jersey 08540

United States of America

Phone: +1.732.329.8885

Number of Employees: 186

http://cytosorbents.com

Description

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.